Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The global orthopedic surgical robotic device market will grow rapidly through 2027, driven by increasing penetration of this currently underused technology, expanding treatable populations, and an increase in clinical evidence that supports the benefits of robotic surgery.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic surgical robotic devices in US, Europe, and Asia Pacific across a 10-year period.
Expansion into new indications is increasing the total treatable population and driving growth in the orthopedic surgical robotic market.
What is the penetration of robotics into the various orthopedic procedures?
Which robotic-assisted procedures will see the highest growth?
How does the penetration and growth of robotic-assisted procedures differ between geographical regions?
Competition in this market is becoming more intense as new robotic systems receives regulatory approval
Who are the competitors in this market and what are their strengths and weaknesses?
What are the key strategies adopted by these competitors and how will it impact the competitive landscape?
Who are the likely new entrants into this market going forward?
The orthopedic surgical robotic market is hindered by cost and availability of alternative technologies.
What are the alternative technologies that could also improve clinical outcomes?
How will the cost of robotic systems change through 2027?
Already a Client? Log in to access this report.
Xi Chen is a principal analyst within the Medtech Insights division at Decision Resources Group, focusing on improving spreadsheet and data management processes across Medtech Insights; additionally, Xi has extensive experience in the fields of spinal implants, joint reconstruction, general surgery, and robotic surgery. Xi holds a in Biomedical Engineering from the University of Toronto.
Lucy Guan is an analyst within the Endoscopy and Aesthetics Medtech Insights team at Decision Resources Group, with extensive knowledge in the markets for endoscope servicing, video and high-tech hardware devices, and laparoscopic devices. Lucy holds an Honors Bachelor's degree and a Master's degree in Medical Science from the University of Toronto.